Glaucine suppresses IL-16/CD4 to alleviate neuropathic pain via spinal p56lck-NMDA receptor signaling. - Li X; Wang R; Ma X; Yang J; Zhang S; Zhang Z; Jiang H; Liu J; Yu B; Dai W (Naunyn-Schmiedeberg's archives of pharmacology, 2026)